Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.
about
In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression.The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor.
P2860
Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Resistance studies of a dithia ...... inhibitor in replicon systems.
@ast
Resistance studies of a dithia ...... inhibitor in replicon systems.
@en
type
label
Resistance studies of a dithia ...... inhibitor in replicon systems.
@ast
Resistance studies of a dithia ...... inhibitor in replicon systems.
@en
prefLabel
Resistance studies of a dithia ...... inhibitor in replicon systems.
@ast
Resistance studies of a dithia ...... inhibitor in replicon systems.
@en
P2093
P2860
P356
P1476
Resistance studies of a dithia ...... inhibitor in replicon systems.
@en
P2093
Andrew Yueh
Chi-Chen Yang
Han-Shu Hu
Hui-Mei Lin
Jing-Chyi Wang
Jyh-Haur Chern
Pei-Shan Wu
Su-Ying Wu
Teng-Kuang Yeh
Tsu-An Hsu
P2860
P304
P356
10.1128/AAC.01403-12
P407
P577
2012-11-19T00:00:00Z